Estados financieros detallados de Inventiva S.A. (IVA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Inventiva S.A. registró ingresos de $4.5M en el último ejercicio fiscal, con un CAGR de 5 años del 64.5%.
Márgenes de los últimos 12 meses: margen bruto 35.1%, margen operativo -30.4%, margen neto -79.0%.
Al precio actual de $3.79, IVA presenta beneficios negativos (P/E no significativo) y un ROE del 18.70%. La capitalización bursátil es de $197M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $9.4M | $6.5M | $3.2M | $7.0M | $372000 | $4.2M | $12.2M | $17.5M | $9.2M | $4.5M |
| Coste de Ventas | $1.5M | $1.2M | $967000 | 0 | $846000 | $1.0M | $995000 | -$23000 | $3.9M | $2.8M |
| Beneficio Bruto | $8.0M | $5.3M | $2.2M | $7.0M | $4.4M | $4.2M | $17.1M | $17.5M | $9.2M | $1.5M |
| I+D | $22.1M | $26.7M | $31.6M | $33.8M | $23.7M | $48.5M | $60.5M | $110.0M | $90.9M | $83.6M |
| Generales y Administrativos | $3.3M | $4.1M | $4.5M | $4.5M | $9.1M | $11.5M | $15.5M | $15.6M | $17.1M | $53.9M |
| Gastos Operativos | $21.5M | $27.0M | $36.4M | $36.2M | $34.1M | $56.3M | $74.2M | $120.2M | $106.8M | $137.4M |
| Beneficio Operativo | -$13.0M | -$20.9M | -$33.3M | -$30.3M | -$29.7M | -$52.1M | -$57.1M | -$102.7M | -$97.6M | -$130.9M |
| EBITDA | -$11.1M | -$22.0M | -$32.0M | -$28.8M | -$31.8M | -$52.8M | -$56.3M | -$102.0M | -$166.5M | -$128.2M |
| Gastos por Intereses | $7548 | $5316 | $243028 | $3000 | $66000 | $138000 | $707000 | $5.2M | $12.2M | $32.3M |
| Beneficio Antes de Impuestos | -$12.6M | -$20.6M | -$33.4M | -$30.2M | -$33.6M | -$49.3M | -$54.3M | -$109.8M | -$183.9M | -$342.3M |
| Impuestos | -$5.5M | -$3.4M | $253000 | 0 | 0 | $364000 | -$20000 | $607000 | $313000 | $22000 |
| Beneficio Neto | -$7.0M | -$17.2M | -$33.6M | -$30.2M | -$33.6M | -$49.6M | -$54.3M | -$110.4M | -$184.2M | -$340.2M |
| BPA | $-0.45 | $-1.11 | $-1.64 | $-1.28 | $-0.99 | $-1.27 | $-1.31 | $-2.43 | $-3.54 | $-1.82 |
| BPA Diluido | $-0.45 | $-1.11 | $-1.64 | $-1.28 | $-0.99 | $-1.27 | $-1.31 | $-2.43 | $-3.54 | $-1.82 |
| Acciones en Circulación (Diluidas) | $15.7M | $15.5M | $20.5M | $23.5M | $33.9M | $39.2M | $41.4M | $45.4M | $52.0M | $186.8M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $24.9M | $59.1M | $56.7M | $35.8M | $105.7M | $86.6M | $86.7M | $26.9M | $96.6M | $99.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $7.3M | 0 | $1.0M | $70000 | 0 | 0 |
| Cuentas por Cobrar | $4.5M | $6.9M | $13.3M | $643000 | $48000 | $11.6M | $279000 | $15.7M | $12.2M | $9.1M |
| Inventario | $471879 | $473129 | $410000 | $387000 | $320000 | $392000 | $373000 | $417000 | 0 | 0 |
| Activos Corrientes | $41.2M | $67.2M | $71.6M | $48.9M | $133.0M | $115.6M | $106.4M | $48.2M | $111.5M | $243.8M |
| Inmovilizado Material | $5.0M | $4.5M | $4.3M | $3.7M | $3.3M | $3.2M | $7.4M | $9.1M | $5.0M | $3.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $2.1M | $1.8M | $1.5M | $1.2M | $935000 | $770000 | $568000 | $541000 | $48000 | $181921 |
| Activos Totales | $48.9M | $74.4M | $79.8M | $57.0M | $138.9M | $122.0M | $116.0M | $69.6M | $119.0M | $248.9M |
| Cuentas por Pagar | $4.4M | $5.4M | $8.4M | $7.5M | $6.9M | $14.6M | $19.4M | $37.7M | $32.9M | $26.0M |
| Deuda a Corto | $145746 | $307000 | $2.1M | $77000 | $16000 | $1.2M | $4.6M | $3.0M | $3.3M | $30.3M |
| Pasivos Corrientes | $8.6M | $8.8M | $15.1M | $13.9M | $13.9M | $22.9M | $30.7M | $50.2M | $120.7M | $77.3M |
| Deuda a Largo | $481858 | $220000 | $74000 | 0 | $10.0M | $8.7M | $25.4M | $27.9M | $46.3M | $24.8M |
| Pasivos Totales | $13.1M | $10.4M | $18.2M | $15.6M | $27.7M | $33.1M | $70.5M | $101.6M | $225.6M | $277.9M |
| Reservas | -$7.0M | -$17.2M | -$33.6M | -$30.2M | -$33.6M | -$49.6M | -$54.3M | -$110.4M | -$184.2M | -$354.1M |
| Patrimonio Neto | $35.7M | $64.0M | $61.6M | $41.4M | $111.2M | $88.9M | $45.5M | -$32.0M | -$106.6M | -$29.0M |
| Deuda Total | $627604 | $482066 | $2.2M | $114000 | $10.1M | $10.1M | $34.5M | $37.5M | $54.3M | $59.4M |
| Deuda Neta | -$24.2M | -$58.6M | -$54.5M | -$35.7M | -$103.0M | -$76.4M | -$53.3M | $10.1M | -$42.2M | -$39.9M |
| Capital Circulante | $32.6M | $58.4M | $56.6M | $35.0M | $119.1M | $92.7M | $75.7M | -$2.0M | -$9.2M | $166.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$7.0M | -$17.2M | -$33.6M | -$30.2M | -$33.6M | -$49.6M | -$54.3M | -$110.4M | -$184.2M | -$340.2M |
| Amortizaciones | $1.6M | $1.4M | $2.3M | $1.6M | $1.9M | -$1.3M | $1.7M | $2.6M | $5.2M | $3.2M |
| Compensación en Acciones | $3.1M | $683606 | $833000 | $1.4M | $938000 | $2.1M | $2.2M | $4.0M | $3.6M | $26.8M |
| Cambio en Capital Circulante | -$2.7M | $2.5M | $974000 | -$769000 | -$2.0M | $979000 | $5.7M | $17.3M | $1.7M | $6.4M |
| Flujo de Caja Operativo | -$14.9M | -$17.0M | -$34.2M | -$28.4M | -$30.6M | -$47.6M | -$44.9M | -$81.6M | -$85.9M | -$101.0M |
| Inversiones (CapEx) | -$227937 | -$428029 | -$549000 | -$136000 | -$292000 | -$534000 | -$561000 | -$540000 | -$333000 | -$237255 |
| Adquisiciones | $17.4M | $6.2M | 0 | $3000 | 0 | $89000 | $41000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$15.1M | -$17.4M | -$34.8M | -$28.5M | -$30.9M | -$48.2M | -$45.5M | -$82.2M | -$86.3M | -$101.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -31.0% | -51.0% | +118.9% | -94.7% | +1027.4% | +190.4% | +43.5% | -47.4% | -51.3% | |
| Crecimiento Beneficio Neto (anual) | -144.6% | -95.1% | +10.1% | -11.2% | -47.6% | -9.3% | -103.5% | -66.8% | -84.7% | |
| Crecimiento BPA (anual) | -146.7% | -47.7% | +22.0% | +22.7% | -28.3% | -3.1% | -85.5% | -45.7% | +48.6% | |
| Cambio en Acciones (anual) | -1.4% | +32.4% | +14.5% | +44.0% | +15.6% | +5.8% | +9.4% | +14.6% | +259.4% | |
| Crecimiento FCF (anual) | -15.5% | -99.4% | +17.9% | -8.2% | -56.0% | +5.6% | -80.6% | -5.0% | -17.3% | |
| Margen Bruto | 84.3% | 81.0% | 69.8% | 100.0% | 1187.4% | 100.0% | 140.1% | 100.1% | 100.0% | 33.7% |
| Margen Operativo | -137.8% | -320.8% | -1040.1% | -433.2% | -7988.7% | -1242.6% | -468.9% | -587.7% | -1060.6% | -2921.0% |
| Margen EBITDA | -118.0% | -337.4% | -1002.2% | -410.9% | -8541.7% | -1258.0% | -462.2% | -583.9% | -1810.4% | -2858.6% |
| Margen Neto | -74.6% | -264.2% | -1051.5% | -431.9% | -9037.4% | -1183.5% | -445.6% | -631.8% | -2002.7% | -7587.8% |
| Margen FCF | -159.7% | -267.3% | -1087.1% | -407.8% | -8301.6% | -1148.4% | -373.5% | -470.1% | -937.8% | -2257.9% |
| Tasa Impositiva Efectiva | 43.9% | 16.5% | -0.8% | -0.0% | -0.0% | -0.7% | 0.0% | -0.6% | -0.2% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.96 | $-1.12 | $-1.69 | $-1.21 | $-0.91 | $-1.23 | $-1.10 | $-1.81 | $-1.66 | $-0.54 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $15.7M | $15.5M | $20.5M | $23.5M | $33.9M | $39.2M | $41.4M | $45.4M | $52.0M | $186.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 1870.38% |
| Rentabilidad sobre capital invertido | -66.18% |
| Rentabilidad sobre activos | -141.93% |
| Margen bruto | 35.07% |
| Margen operativo | -3037.30% |
| Margen neto | -7899.58% |
Salud financiera
| Deuda / Patrimonio | -2.10 |
| Ratio corriente | 3.16 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -29.82 | -12.09 | -8.18 | -10.48 | -14.65 | -10.76 | -3.40 | -1.86 | -0.60 | -2.55 |
| P/VC | 5.89 | 3.25 | 4.48 | 7.63 | 4.42 | 6.02 | 4.07 | -6.40 | -1.04 | -29.92 |
| P/V | 22.28 | 31.93 | 86.22 | 45.10 | 1320.39 | 127.57 | 15.18 | 11.73 | 12.09 | 193.76 |
| Margen Bruto | 84.3% | 81.0% | 69.8% | 100.0% | 1187.4% | 100.0% | 140.1% | 100.1% | 100.0% | 33.7% |
| Margen Operativo | -137.8% | -320.8% | -1040.1% | -433.2% | -7988.7% | -1242.6% | -468.9% | -587.7% | -1060.6% | -2921.0% |
| Margen Neto | -74.6% | -264.2% | -1051.5% | -431.9% | -9037.4% | -1183.5% | -445.6% | -631.8% | -2002.7% | -7587.8% |
Empresas relacionadas: AVTX · CRBU · ENTA · EPRX · GNFT · IVVD · NAUT
Explorar sector: Healthcare · Biotechnology
Más secciones de IVA: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones